Zim Laboratories Limited has informed the Exchange regarding 'Amendment to the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (Code of Fair Disclosure and Conduct)'.
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories Limited has informed the stock exchange about an amendment to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI), also known as the Code of Fair Disclosure and Conduct. This code is part of the company's internal framework to comply with SEBI's Insider Trading Regulations. Amending such codes is a routine compliance exercise, often done to align with regulatory updates or to strengthen internal controls around price-sensitive information. No specific details of the amendments have been disclosed in this filing. The change is purely governance-related and does not indicate any regulatory action against the company.
This is a routine regulatory compliance update with no material impact on the company's financials, operations, or shareholders. Investors need not take any action, and this filing is unlikely to influence the stock price.